EMBC · Embecta Corp
United States · RS rating 71 · As of 2026-11-03
| Price | 6.08 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 71 / 67 / 96 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 33 / 30 |
| Industry group (rank) | Medical-Supplies (51) |
| EPS growth Q/Q | +64.4% |
| Sales growth Q/Q | -1.1% |
| Distance from 52-week high | +58.5% |
| Market cap (USD) | $541.9M |